Maze Therapeutics CSBO Dandekar Atul exercised Options for 12,500 shares at $0 on Sep. 1, 2026. The transaction matters to investors because post-transaction ownership was recorded at 38,750 shares, while derivative securities ownership stood at 12,500 after the exercise was completed.

Key Highlights

  • Dandekar Atul owned 12,500 derivative securities after the transaction.
  • The transaction carried SEC transaction code M and occurred on Sep. 1, 2026.
  • Dandekar Atul is identified in the filing as Maze Therapeutics’ CSBO.

Maze Therapeutics, Inc. (NASDAQ: MAZE) saw CSBO Dandekar Atul exercise options for 12,500 shares at $0 on Sep. 1, 2026. The transaction left Dandekar Atul with 38,750 shares, according to the post-transaction ownership record.

Option Exercise Details

The transaction was recorded under SEC transaction code M. Dandekar Atul exercised options covering 12,500 derivative securities of Maze Therapeutics on the same date. The exercise price for the shares was $0. Dandekar Atul is identified as Maze Therapeutics’ CSBO.

Post-Transaction Ownership

Following the exercise, Dandekar Atul’s reported ownership included 38,750 shares of Maze Therapeutics. The post-transaction record also showed ownership of 12,500 derivative securities.